Nerve growth factor (2.5s, Shengri Medicine)

神经生长因子（2.5s，圣日医药）

Report date: 2024/12/18 10:01:29

Base Information

Drug NameNerve growth factor (2.5s, Shengri Medicine)
Drug Alias Name神经生长因子(2.5s) - 圣日医药恩即复
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionNeurons stimulantsNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsTrauma, Nervous SystemPeripheral Nervous System DiseasesBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (NDA/BLA)
Highest Status in ChinaPending
Originator CompaniesBeijing Zhengda Tianyuan Biotechnology Co LtdBeijing Shengri Pharmaceutical Technology Development Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Zhengda Tianyuan Biotechnology Co LtdBeijing Shengri Pharmaceutical Technology Development Co Ltd
Active IndicationsN/A
Inactive IndicationsTrauma, Nervous SystemPeripheral Nervous System DiseasesBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A